You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy
|
|---|---|
| Published in |
JAMA Dermatology, March 2024
|
| DOI | 10.1001/jamadermatol.2023.5679 |
| Pubmed ID | |
| Authors |
Billal Tedbirt, Maud Maho-Vaillant, Estelle Houivet, Claire Mignard, Marie-Laure Golinski, Sébastien Calbo, Catherine Prost-Squarcioni, Bruno Labeille, Catherine Picard-Dahan, Guillaume Chaby, Marie-Aleth Richard, Emmanuelle Tancrede-Bohin, Sophie Duvert-Lehembre, Emmanuel Delaporte, Philippe Bernard, Frédéric Caux, Marina Alexandre, Philippe Musette, Saskia Ingen-Housz-Oro, Pierre Vabres, Gaëlle Quereux, Alain Dupuy, Sébastien Debarbieux, Martine Avenel-Audran, Michel D’Incan, Christophe Bédane, Nathalie Bénéton, Denis Jullien, Nicolas Dupin, Laurent Misery, Laurent Machet, Marie Beylot-Barry, Olivier Dereure, Bruno Sassolas, Jacques Benichou, Pascal Joly, Vivien Hébert |
X Demographics
The data shown below were collected from the profiles of 37 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 7 | 19% |
| United States | 3 | 8% |
| Colombia | 3 | 8% |
| Spain | 2 | 5% |
| Venezuela, Bolivarian Republic of | 2 | 5% |
| Switzerland | 1 | 3% |
| Guatemala | 1 | 3% |
| India | 1 | 3% |
| Nepal | 1 | 3% |
| Other | 2 | 5% |
| Unknown | 14 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 29 | 78% |
| Scientists | 4 | 11% |
| Practitioners (doctors, other healthcare professionals) | 4 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 4 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 1 | 25% |
| Unknown | 3 | 75% |
| Readers by discipline | Count | As % |
|---|---|---|
| Sports and Recreations | 1 | 25% |
| Medicine and Dentistry | 1 | 25% |
| Unknown | 2 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 73. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 May 2024.
All research outputs
#600,851
of 25,890,819 outputs
Outputs from JAMA Dermatology
#428
of 6,622 outputs
Outputs of similar age
#8,769
of 325,981 outputs
Outputs of similar age from JAMA Dermatology
#7
of 128 outputs
Altmetric has tracked 25,890,819 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,622 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.5. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 325,981 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 128 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.